Top Markets
#1 Black Phoenix Black Phoenix +827.96%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +26.72%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.63%
#4 pipedog pipedog +22.83%
#5 Bless Bless +22.61%
#6 SAFEcoin SAFEcoin +21.43%
#7 Beam Beam +20.30%
#8 Magma Finance Magma Finance +19.68%
#9 PondCoin PondCoin +18.61%
#10 YFSX YFSX +16.00%
Coin of the day
Black Phoenix Black Phoenix
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Zymeworks Inc. Zymeworks Inc.

Zymeworks Inc.

ZYME
Xếp hạng trong cổ phiếu #6233
Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase,... Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed at combating cancer. Its pipeline features two primary experimental treatments: zanidatamab, a cutting-edge bispecific antibody currently undergoing Phase 1 and Phase 2 studies for various malignancies such as those affecting the biliary tract, gastroesophageal region (adenocarcinomas), breast, and colon; and ZW49, an antibody-drug conjugate targeting two sites on the human epidermal growth factor receptor 2 (HER2), which is in Phase 1 trials for advanced or spreading tumors that express HER2. Zymeworks maintains significant alliances with several pharmaceutical leaders, including Merck Sharp & Dohme Research Ltd., Eli Lilly and Company, Bristol-Myers Squibb company, GlaxoSmithKline Intellectual Property Development Ltd., Daiichi Sankyo Co., Ltd., Janssen Biotech, Inc., BeiGene, Ltd., and Exelixis, Inc. Furthermore, it engages in cooperative research and licensing agreements with LEO Pharma A/S, specifically for the exploration, advancement, and market introduction of bispecific antibodies, and with Iconic Therapeutics, Inc. Established in 2003, Zymeworks Inc. operates from its headquarters located in Vancouver, Canada.
Giá cổ phiếu
$29.33
Vốn hóa thị trường
$2.16B
Thay đổi (1 ngày)
0.07%
Thay đổi (1 năm)
96.42%
Quốc gia
US
Giao dịch Zymeworks Inc. (ZYME)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của Zymeworks Inc. (ZYME)
Giá đóng cửa cao nhất: $26.22 vào 2026-08-01

Giá đóng cửa thấp nhất: $13.00 vào 2017-04-01
Lịch sử giá cổ phiếu của Zymeworks Inc. từ 2017 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -12.16%
2025 90.41%
2024 44.87%
2023 30.92%
2022 -56.92%
2021 -67.45%
2020 19.67%
2019 233.57%
2018 63.85%
2017 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.48 40.97%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.38%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.50 459.76%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH